Not available
Quote | Ocular Therapeutix Inc. (NASDAQ:OCUL)
Last: | $6.17 |
---|---|
Change Percent: | 0.32% |
Open: | $6.25 |
Close: | $6.17 |
High: | $6.26 |
Low: | $6.05 |
Volume: | 1,186,465 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Ocular Therapeutix Inc. (NASDAQ:OCUL)
2024-05-07 16:35:53 ET More on Ocular Therapeutix Ocular Therapeutix's Impressive Surge: A Strategic Insight Ocular Therapeutix: Diabetic Retinopathy Data Q2 2024 And Wet AMD Advancement Ocular Therapeutix Q1 2024 Earnings Preview Baird sees weakness in Ocula...
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects Randomized in April 2024 Cash Expected to Support Operations Into 2028, Ba...
Message Board Posts | Ocular Therapeutix Inc. (NASDAQ:OCUL)
Subject | By | Source | When |
---|---|---|---|
Tard sells $6.00 call option at $0.15 at | trendzone | investorshub | 02/14/2023 9:02:55 PM |
$OCUL..........................................https://stockcharts.com/h-sc/ui?s= | glenn1919 | investorshub | 02/14/2023 5:30:55 PM |
znewcar1: $OCUL 35% v27,1M c5.23 f77,010M H6.12 ML3.74 gapNgo 134 Views | znewcar1 | investorshangout | 02/14/2023 4:25:16 AM |
znewcar1: 9 views Mind blown. $OCUL 56% v16,8M C6.04 f77,010M H6.05 ML3.74 | znewcar1 | investorshangout | 02/13/2023 7:21:38 PM |
znewcar1: HOD5.99 push a little more for my target please! Thank you6.05 | znewcar1 | investorshangout | 02/13/2023 7:20:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Ocular Therapeutix Inc. Company Name:
OCUL Stock Symbol:
NASDAQ Market:
Ocular Therapeutix Inc. Website:
Recent Leadership Appointments Put Ocular on Track to Become a Leader in Retinal Care Site Activation and Patient Enrollment for AXPAXLI™ SOL-1 Phase 3 wet AMD Trial Progressing with First Subjects Randomized in April 2024 Cash Expected to Support Operations Into 2028, Ba...
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular"), a biopharmaceutical company committed to enh...
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related...